VAI TRÒ CỦA KỸ THUẬT GÂY TẮC ĐỘNG MẠCH TRƯỚC ĐIỀU TRỊ PHẪU THUẬT HO RA MÁU

Abstract

Objective: To describe the clinical and paraclinical characteristics of patients undergoing surgery for hemoptysis at the National Lung Hospital and to evaluate the role of bronchial artery embolization before surgical treatment of hemoptysis in the study group of patients. Subjects and Methods: A cross-sectional descriptive study was conducted on 205 patients aged 16 and above who underwent surgery for hemoptysis at the National Lung Hospital from January 2018 to December 2023. Results: The average age was 50 years, with males accounting for 76% of cases. A history of hemoptysis before hospital admission was noted in 41% of the patients, and most patients had a prior history of lung disease, with pulmonary tuberculosis being the most common, accounting for 55.6%. The imaging findings on computed tomography (CT) scans were quite diverse; the three most common lesions were nodules, consolidations, and fungal masses, with rates of 33.7%, 41.5%, and 48.3%, respectively. The three most common causes were fungal mass, pulmonary tuberculosis, and bronchiectasis, with rates of 40.5%, 19.5%, and 18.5%, respectively. Out of 205 patients who underwent surgery, 57 patients received preoperative bronchial artery embolization (accounting for 27.8%). There was no difference in early surgical outcomes and recurrence rates of hemoptysis between the group that received bronchial artery embolization before surgery and the group that did not. Conclusion: Surgery for hemoptysis can be performed whenever feasible, and preoperative bronchial artery embolization may not be beneficial.